Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mithramycin oxime derivatives having increased selectivity and anti-cancer activity

Mithramycin oxime derivatives having increased selectivity and anti-cancer activity

US Patent 12486300 · Granted Dec 2, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Vascular flow-based microfluidic platform2025
Smartwatch2025
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof2025
Node selection method and apparatus, first node, storage medium, and program pro2025
Anti-CD79B protein monoclonal antibody, products containing the same, and uses t2025
CD80 and CD86 binding protein compositions and uses thereof2025
Beverage container lid2025
Beverage container2025
Method of high precision time synchronization with a communication network grand2025
Endoscope structure2025
Ultrasound system, apparatus, and method for transcranial treatment2025
Driving device for campervan2025